Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219881 · ClinicalTrials.gov registry record · Phase 3

Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery

A Phase 3 study, sponsored by Ohio State University.

Completed
Registry status
Phase 3
Development phase
75
Enrollment target

NCT01219881 is a Phase 3 study that has completed, run by Ohio State University. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219881, a Phase 3 study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
Phase 3
Development phase
75 participants
Enrollment target

Study Summary

This is a single-center, prospective, randomized, double-blind, double-arm trial including 68 subjects scheduled to undergo urological cystoscope surgeries under general anesthesia (GA) with intubation through a laryngeal mask airway (LMA) at The Ohio State University Medical Center (OSUMC). Double blinding will be based on both the subject and the research staff being unaware of which trial arm the subject is randomized into. Eligible subjects that provide voluntary and written informed consent will be included in this study.

Interventions

  • DRUG Sevoflurane
  • DRUG Desflurane

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2010-09
Est. Completion 2012-10
Phase Phase 3

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT01219881

The ClinicalTrials.gov registry entry for NCT01219881 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.

NCT01219881 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01219881 about?

NCT01219881 is a clinical study titled "Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery". This is a single-center, prospective, randomized, double-blind, double-arm trial including 68 subjects scheduled to undergo urological cystoscope surgeries under general anesthesia (GA) with intubation through a laryngeal mask airway (LMA) at The Ohio State University Medical Center (OSUMC). Double ...

What is the current status of trial NCT01219881?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2010-09. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01219881?

The interventions under investigation include: Sevoflurane (DRUG), Desflurane (DRUG).

Who is sponsoring clinical trial NCT01219881?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.